Tag #Critical Medicines Act

Showing 1 to 9 of 9 results

euronews.com

🌐 85% Global Worthiness

Mar 15, 16:12

EU's Critical Medicines Act: 'Buy European' Policy Risks Trade Disputes

The European Commission's Critical Medicines Act, unveiled this week, aims to enhance the EU's medicine supply security by prioritizing EU manufacturing in public procurement and increasing domestic production, but faces funding constraints and lacks a coordinated contingency stockpiling plan.

EU's Critical Medicines Act: 'Buy European' Policy Risks Trade Disputes

The European Commission's Critical Medicines Act, unveiled this week, aims to enhance the EU's medicine supply security by prioritizing EU manufacturing in public procurement and increasing domestic production, but faces funding constraints and lacks a coordinated contingency stockpiling plan.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of the 'Buy European' principle in the Critical Medicines Act, and how might it affect the EU's trade relations?

The European Commission's Critical Medicines Act aims to improve the EU's medicine supply security, prioritizing EU manufacturing in public procurement ('Buy European'). This approach, while intended to bolster supply, risks trade disputes with countries like China, which employs similar protectionist policies.

gr.euronews.com

🌐 85% Global Worthiness

Mar 15, 22:12

EU's Critical Medicines Act: Securing Drug Supply Amid Budgetary and Stockpiling Concerns

The European Commission unveiled its Critical Medicines Act, aiming to secure the EU's drug supply by prioritizing EU-based suppliers via a "Buy European" clause, promoting domestic production, and enhancing joint procurement mechanisms, but facing criticism over its limited budget and lack of emerg...

EU's Critical Medicines Act: Securing Drug Supply Amid Budgetary and Stockpiling Concerns

The European Commission unveiled its Critical Medicines Act, aiming to secure the EU's drug supply by prioritizing EU-based suppliers via a "Buy European" clause, promoting domestic production, and enhancing joint procurement mechanisms, but facing criticism over its limited budget and lack of emerg...

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the Critical Medicines Act address the issue of insufficient EU production of critical medicines?

The "Buy European" initiative aims to reduce reliance on third-country suppliers, potentially sparking trade disputes. The proposal also promotes increased domestic production of critical medicines, but without mandating European manufacturing, focusing instead on strategic partnerships with neighboring countries.

es.euronews.com

🌐 90% Global Worthiness

Mar 9, 16:10

EU Critical Medicines Act Seeks to Address Pharmaceutical Supply Chain Vulnerabilities

The EU's Critical Medicines Act, to be released this week, aims to address Europe's vulnerability in pharmaceutical supply chains by mapping them, supporting domestic production, and diversifying sources, driven by the fact that 80–90% of the world's antibiotics are manufactured in Asia.

EU Critical Medicines Act Seeks to Address Pharmaceutical Supply Chain Vulnerabilities

The EU's Critical Medicines Act, to be released this week, aims to address Europe's vulnerability in pharmaceutical supply chains by mapping them, supporting domestic production, and diversifying sources, driven by the fact that 80–90% of the world's antibiotics are manufactured in Asia.

Progress

60% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does Europe's dependence on Asian pharmaceutical production, especially for antibiotics, pose a significant threat to its healthcare and defense capabilities?

Europe's heavy reliance on Asia, particularly China, for 80-90% of its antibiotic supply, creates a critical vulnerability. Disruptions to this supply chain, as seen during the COVID-19 pandemic, could severely compromise European healthcare systems and even military capabilities. The lack of readily available antibiotics would severely limit surgical procedures and increase the mortality rate of treatable infections.

ru.euronews.com

🌐 85% Global Worthiness

Mar 9, 22:09

EU Ministers Push to Fund Essential Medicines via Defense Budget

Eleven EU health ministers urge integrating a proposed Critical Medicines Act into the EU's defense strategy, aiming to fund essential drug supplies using €800 billion from the "Rearm Europe" plan to address Europe's 60-80% reliance on Asia for pharmaceuticals.

EU Ministers Push to Fund Essential Medicines via Defense Budget

Eleven EU health ministers urge integrating a proposed Critical Medicines Act into the EU's defense strategy, aiming to fund essential drug supplies using €800 billion from the "Rearm Europe" plan to address Europe's 60-80% reliance on Asia for pharmaceuticals.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will integrating essential drug procurement into the EU's new defense fund address Europe's vulnerability to pharmaceutical supply chain disruptions?

Eleven EU health ministers advocate integrating a proposed Critical Medicines Act into the EU's defense strategy, aiming to fund essential drug supplies using the new EU defense funds. This initiative seeks to leverage €800 billion from the "Rearm Europe" plan, ensuring Europe's defense isn't compromised by drug shortages.

euronews.com

🌐 85% Global Worthiness

Jan 31, 22:08

EU Rushes Critical Medicines Act, Bypassing Impact Assessment

The EU is rushing to pass the Critical Medicines Act by March 11th, to address medicine shortages, but will forgo an impact assessment, despite concerns from stakeholders about insufficient consultation and evidence gathering.

EU Rushes Critical Medicines Act, Bypassing Impact Assessment

The EU is rushing to pass the Critical Medicines Act by March 11th, to address medicine shortages, but will forgo an impact assessment, despite concerns from stakeholders about insufficient consultation and evidence gathering.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of the EU's decision to forgo a full impact assessment for the Critical Medicines Act?

The EU aims to pass the Critical Medicines Act by March 11th, addressing medicine shortages. This rushed 100-day timeline omits a standard impact assessment, raising concerns about insufficient consultation and evidence gathering among stakeholders.

es.euronews.com

🌐 85% Global Worthiness

Mar 15, 16:12

EU's Critical Medicines Act: 'Buy European' Clause and Funding Concerns

The European Commission's proposed Critical Medicines Act aims to improve EU medicine supply security through a 'Buy European' clause, new medicine categories, and improved joint procurement, but faces criticism for insufficient funding (€83 million for 2026-2027) and the lack of contingency stockpi...

EU's Critical Medicines Act: 'Buy European' Clause and Funding Concerns

The European Commission's proposed Critical Medicines Act aims to improve EU medicine supply security through a 'Buy European' clause, new medicine categories, and improved joint procurement, but faces criticism for insufficient funding (€83 million for 2026-2027) and the lack of contingency stockpi...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term risks of the absence of a harmonized EU-wide framework for contingency stockpiling of critical medicines?

The Act's success hinges on overcoming funding limitations and potential trade conflicts. The lack of a coordinated contingency stockpiling framework weakens the overall resilience of the EU's medicine supply chain. Future implications include strained international relations and uneven access to essential medicines across member states.

politico.eu

🌐 75% Global Worthiness

Mar 12, 07:12

EU's Critical Medicines Act Unveiled Amidst Concerns Over Drug Shortages

The European Commission's Critical Medicines Act aims to tackle chronic drug shortages by overhauling procurement rules, promoting joint purchasing, and providing €88.5 million in subsidies, but faces criticism for insufficient funding and weak stockpiling measures.

EU's Critical Medicines Act Unveiled Amidst Concerns Over Drug Shortages

The European Commission's Critical Medicines Act aims to tackle chronic drug shortages by overhauling procurement rules, promoting joint purchasing, and providing €88.5 million in subsidies, but faces criticism for insufficient funding and weak stockpiling measures.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the act aim to address the root causes of drug shortages, and what are the potential limitations of its approach?

The act overhauls procurement rules, encouraging contracts based on supply security rather than price. It also promotes joint procurement among member states for various medicines, including cancer drugs and antimicrobials. This approach aims to strengthen supply chains and improve access to essential and high-cost medications.

tr.euronews.com

🌐 85% Global Worthiness

Mar 9, 16:10

EU Health Ministers Propose Integrating Critical Medicines Act into Defense Fund

Health ministers from 11 EU countries proposed integrating the upcoming Critical Medicines Act into the EU's defense fund, aiming to bolster pharmaceutical security and leverage €800 billion in planned defense spending. This reflects concerns about Europe's reliance on Asian pharmaceutical productio...

EU Health Ministers Propose Integrating Critical Medicines Act into Defense Fund

Health ministers from 11 EU countries proposed integrating the upcoming Critical Medicines Act into the EU's defense fund, aiming to bolster pharmaceutical security and leverage €800 billion in planned defense spending. This reflects concerns about Europe's reliance on Asian pharmaceutical productio...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term implications of this proposal for EU health funding and budget rules, and what challenges might arise from its implementation?

The proposal could significantly alter EU health spending. While the EU4Health program initially received €5.3 billion, recent budget cuts raise concerns about future funding. The proposed mechanism would allow increased national health spending by relaxing EU budget rules, potentially exempting defense spending (including critical medicines) up to 1.5% of GDP from spending limits for four years. The EU Commission and Parliament's response to this proposal will be crucial.

tr.euronews.com

🌐 85% Global Worthiness

Feb 28, 22:09

Pharmaceutical Firms Oppose EU's Rushed Medicine Shortage Act

The European Commission's proposed Critical Medicines Act, aiming to prevent medicine shortages in the EU by March 11th, faces opposition from major pharmaceutical companies like Roche and Bayer due to concerns over insufficient impact assessment and rushed preparation, prompting calls for a more th...

Pharmaceutical Firms Oppose EU's Rushed Medicine Shortage Act

The European Commission's proposed Critical Medicines Act, aiming to prevent medicine shortages in the EU by March 11th, faces opposition from major pharmaceutical companies like Roche and Bayer due to concerns over insufficient impact assessment and rushed preparation, prompting calls for a more th...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the main arguments raised by pharmaceutical companies against the Critical Medicines Act, and how do these concerns relate to the Commission's stated goals?

Pharmaceutical companies argue the Critical Medicines Act lacks thorough analysis of its consequences, particularly for small and medium-sized enterprises. Groups like EUCOPE and EFPIA echo these concerns, emphasizing the need for a comprehensive impact assessment before implementation. This highlights a conflict between the Commission's urgency to address medicine shortages and the industry's call for more careful consideration.

Showing 1 to 9 of 9 results